Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 689391, 8 pages
http://dx.doi.org/10.1155/2014/689391
Research Article

Formulation Optimization of Erythromycin Solid Lipid Nanocarrier Using Response Surface Methodology

University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur 492010, India

Received 28 February 2014; Revised 17 May 2014; Accepted 28 May 2014; Published 18 June 2014

Academic Editor: Yunfeng Lin

Copyright © 2014 Anil Kumar Sahu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Marian, B. Tiţa, T. Jurca, A. Fuliaş, L. Vicaş, and D. Tiţa, “Thermal behaviour of erythromycin-active substance and tablets,” Journal of Thermal Analysis and Calorimetry, vol. 111, no. 2, pp. 1025–1031, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. N. S. Ganesh, M. Deecaraman, B. Ramesh, and P. A. Kulkarni, “Orodispersible—slow releasing erythromycin tablets,” International Journal of PharmTech Research, vol. 3, pp. 600–605, 2011. View at Google Scholar
  3. R. Pignatello, A. Mangiafico, B. Ruozi, G. Puglisi, and P. M. Furneri, “Amphiphilic erythromycin-lipoamino acid ion pairs: characterization and in vitro microbiological evaluation,” AAPS PharmSciTech, vol. 12, no. 2, pp. 468–475, 2011. View at Google Scholar · View at Scopus
  4. C. Puglia, P. Blasi, L. Rizza et al., “Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation,” International Journal of Pharmaceutics, vol. 357, no. 1-2, pp. 295–304, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. R. H. Müller, M. Radtke, and S. A. Wissing, “Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations,” Advanced Drug Delivery Reviews, vol. 54, supplement 1, pp. S131–S155, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. L. S. Kotikalapudi, L. Adepu, J. V. Ratna, and P. V. Diwan, “Formulation and in-vitro characterization of domperidone loaded solid lipid nanoparticles,” International Journal of Pharmaceutical and Biomedical Research, vol. 3, pp. 22–29, 2012. View at Google Scholar
  7. X. Zhang, J. Liu, H. Qiao et al., “Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology,” Powder Technology, vol. 197, no. 1-2, pp. 120–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. S. Chalikwar, V. S. Belgamwar, V. R. Talele, S. J. Surana, and M. U. Patil, “Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system,” Colloids and Surfaces B: Biointerfaces, vol. 97, pp. 109–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. R. Aji Alex, A. J. Chacko, S. Jose, and E. B. Souto, “Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting,” European Journal of Pharmaceutical Sciences, vol. 42, no. 1-2, pp. 11–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K. C. Song, H. S. Lee, I. Y. Choung, K. I. Cho, Y. Ahn, and E. J. Choi, “The effect of type of organic phase solvents on the particle size of poly(D,L-lactide-co-glycolide) nanoparticles,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 276, no. 1–3, pp. 162–167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Manjunath and V. Venkateswarlu, “Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration,” Journal of Controlled Release, vol. 107, no. 2, pp. 215–228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Kalam, Y. Sultana, A. Ali, M. Aqil, A. K. Mishra, and K. Chuttani, “Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system,” Journal of Drug Targeting, vol. 18, no. 3, pp. 191–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Rahman, A. S. Zidan, and M. A. Khan, “Non-destructive methods of characterization of risperidone solid lipid nanoparticles,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 76, no. 1, pp. 127–137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C.-H. Liu and C.-T. Wu, “Optimization of nanostructured lipid carriers for lutein delivery,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 353, no. 2-3, pp. 149–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Paliwal, S. Rai, B. Vaidya et al., “Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 5, no. 2, pp. 184–191, 2009. View at Publisher · View at Google Scholar · View at Scopus